Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study

Affiliations

• ¹ Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, P. R China.
• ² Renmin Hospital of Wuhan University, Wuhan, P. R China.
• ³ Huangmei People's Hospital, Huanggang, P. R. China.
• ⁴ Tongji Hospital of Huazhong University of Science and Technology, Wuhan, P. R. China.
• ⁵ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
• ⁶ Jinan Center for Disease Control and Prevention, P. R China.
• ⁷ State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, P. R. China.
• ⁸ School of Health Sciences, Wuhan University, Wuhan, P. R. China.
• ⁹ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: fang_lq@163.com.
• ¹⁰ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: lihao_1986@126.com.
• ¹¹ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: liuwei@bmi.ac.cn.